Data as of Aug 01
| +0.02 / +0.17%|
The 5 analysts offering 12-month price forecasts for Aratana Therapeutics Inc have a median target of 27.00, with a high estimate of 38.00 and a low estimate of 22.00. The median estimate represents a +133.56% increase from the last price of 11.56.
The current consensus among 6 polled investment analysts is to Buy stock in Aratana Therapeutics Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.